Alibaba, U.S. Payment Processor to Pay $600 Million in DOJ Settlement Over Illegal Drug Sales
Alibaba and a U.S. payment processor have agreed to a $600 million settlement with the Department of Justice regarding illegal product sales.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Alibaba and an unnamed U.S. payment processor are set to pay $600 million to resolve a Department of Justice probe. The investigation centers on allegations that the entities allowed the sale of illegal pharmaceuticals and banned goods to buyers in the United States.
Coverage from outlets including Reuters, AP News, and the Wall Street Journal emphasizes the scale of the financial penalty. Bloomberg, Fox Business, and the South China Morning Post highlight that the settlement addresses failures to stop the distribution of illegal drugs and specialized equipment.
Future developments will depend on the release of specific compliance requirements mandated by the Department of Justice. Coverage does not yet specify the timeline for payment or the identity of the U.S. payment processor involved.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 90d ago.
Quick answers
What is the total value of the settlement?
The settlement total is $600 million.
Who is involved in the settlement alongside Alibaba?
A U.S. payment processor is involved, though coverage does not yet specify its name.
What were the primary allegations against Alibaba?
The Department of Justice alleged that Alibaba allowed the sale of illegal pharmaceuticals and banned equipment to U.S. buyers.
Coverage (8)
- Alibaba and Affiliate to Pay $600 Million in U.S. Settlement Over Illegal Drug Sales The Information · 90d ago
- Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales ABC News - Breaking News, Latest News and Videos · 90d ago
- DOJ says Alibaba failed to stop illegal pharmaceuticals and banned goods from reaching US buyers Fox Business · 90d ago
- Alibaba agrees to pay US$600 million to settle US probe into illegal product sales South China Morning Post · 90d ago
- Alibaba to pay $600M to settle allegations it allowed illegal drug and equipment sales AP News · 90d ago
- Alibaba to pay $600 million to resolve US drug sales probe Reuters · 90d ago
- Alibaba, Payment Firm Will Pay $600 Million to Resolve US Probe Bloomberg · 90d ago
- Alibaba, U.S. Payment Processor to Pay $600 Million in DOJ Settlement Over Illegal Drug Sales WSJ · 90d ago
Topics
Related trends
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Eli Lilly's experimental triple agonist drug retatrutide demonstrates significant weight loss and A1C reduction in clinical trials.
China Broadens Travel Curbs to Encompass Family of Top AI Talent
China expands travel restrictions and exit controls to include families of top artificial intelligence and semiconductor talent.
Scientists are finally starting to figure out Alzheimer’s
Recent breakthroughs in mouse models and the emergence of new drug frontiers are signaling a shift in the scientific understanding of Alzheimer's disease.
China Weighs Allowing Purchases of New Nvidia Chips by ByteDance, Alibaba
China is reportedly considering allowing domestic tech giants ByteDance and Alibaba to purchase new Nvidia chips despite existing restrictions.
Amazon October Prime Day is almost here: Everything we know about the Big Deal Days savings event
Early deals emerge as Amazon prepares for its upcoming October Prime Day savings event.
Former Dallas 'We Buy Ugly Houses' franchisee sentenced to federal prison for investment scam - FOX 4 News Dallas-Fort Worth
A former Dallas franchisee linked to 'We Buy Ugly Houses' receives a 15-year federal prison sentence for a multi-million dollar fraud scheme.